{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:04Z","timestamp":1772165704492,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"hunan provincial commission of health and family planning","award":["hunan provincial commission of health and family planning"],"award-info":[{"award-number":["hunan provincial commission of health and family planning"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To evaluate the medium-and long-term effect of intravascular interventional therapy for symptomatic severe basilar artery stenosis supported by multimodal imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>After strict screening of 67 patients with symptomatic severe basilar artery stenosis (70\u201399%) with atherosclerotic stenosis, 67 patients with symptomatic recurrence after intensive drug treatment were treated with intravascular balloon dilatation and Enterprise stent implantation. Any stroke or death within 30\u2009days after operation and any stroke and restenosis during medium-and long-term follow-up were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\u2460The mean age of 67 patients (67lesions) was 57\u2009\u00b1\u20098\u2009years old, and the technical success rate was 100%; \u2461Preoperative angiography showed that the collateral circulation was poor, and TICI was 1-2a while postoperative angiography showed that TICI was significantly improved to 2b-3; \u2462The average preoperative stenosis rate was 82\u2009\u00b1\u20099%, and the postoperative stenosis rate was reduced to 17\u2009\u00b1\u200910%; \u2463Before surgery, abnormal perfusion was found in the posterior circulation CTP; After the postoperative re-examination, the posterior circulation of CTP perfusion was significantly improved; \u2464Postoperative symptoms and neurological conditions improved significantly; \u2465Complications of perforating branch event occurred in 1 case after operation, and symptoms were relieved after more than 1\u2009month of medication treatment, and mild neurological dysfunction remained. 1 case developed subacute thrombosis in the stent, which improved after active intra-arterial thrombolysis, and there was no residual neurological dysfunction; and 1 case of micro-guide wire being trapped by the distal vasospasm. \u246667 patients were followed up by telephone, WeChat or imaging for 36\u201366\u2009months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In summary intravascular balloon dilation + Enterprise stent implantation is safe and effective for the treatment of symptomatic severe atherosclerotic stenosis of the basilar artery, with high technical success rate, low perioperative complications, and good mid-term and long-term effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-020-01863-5","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T06:03:45Z","timestamp":1596175425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Medium- and long-term effects of endovascular treatments for severely stenotic basilar arteries supported by multimodal imaging"],"prefix":"10.1186","volume":"20","author":[{"given":"Yuanzhi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenfa","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ligang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongliang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"1863_CR1","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.116.025250","volume":"135","author":"W Wang","year":"2017","unstructured":"Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China. Circulation. 2017;135:759\u201371.","journal-title":"Circulation."},{"issue":"2","key":"1863_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1161\/STROKEAHA.116.015031","volume":"48","author":"Z Wang","year":"2017","unstructured":"Wang Z, Hu S, Sang S, et al. Age-period-cohort analysis of stroke mortality in China data from the global burden of disease study 2013. Stroke. 2017;48(2):271\u20135.","journal-title":"Stroke"},{"issue":"1","key":"1863_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/1591019917736032","volume":"24","author":"J Wang","year":"2018","unstructured":"Wang J, Zhong CY, Zhang Y, Wei Y, Liu H, Wu C, et al. Seven years\u2019 follow-up of compara -tive study between stenting and medication for treatment of sym -ptomatic vertebrobasilar artery stenosis. Interv Neuroradiol. 2018;24(1):43\u201350.","journal-title":"Interv Neuroradiol"},{"key":"1863_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/STROKEAHA.113.003508","volume":"45","author":"Y Wang","year":"2014","unstructured":"Wang Y, Zhao X, Liu L, et al. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese intracranial atherosclerosis (CICAS) study. Stroke. 2014;45:663\u20139.","journal-title":"Stroke"},{"issue":"3","key":"1863_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/svn-2018-000158","volume":"3","author":"W Yu","year":"2018","unstructured":"Yu W, Jiang W-J. Stenting for intracranial stenosis: potential future for the prevention of disabling or fatal stroke. Stroke Vasc Neurol. 2018;3(3):140\u20136.","journal-title":"Stroke Vasc Neurol"},{"issue":"7","key":"1863_CR6","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1161\/01.STR.29.7.1389","volume":"29","author":"Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group","year":"1998","unstructured":"Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke. 1998;29(7):1389\u201392.","journal-title":"Stroke"},{"issue":"9921","key":"1863_CR7","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/S0140-6736(13)61088-0","volume":"383","author":"AI Qureshi","year":"2014","unstructured":"Qureshi AI, Caplan LR. Intracranial atherosclerosis. Lancet. 2014;383(9921):984\u201398.","journal-title":"Lancet"},{"issue":"1","key":"1863_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/1591019917736032","volume":"24","author":"J Wang","year":"2018","unstructured":"Wang J, Zhong CY, Zhang Y, et al. Seven years\u2019 follow-up of com -parative study between stenting and medication for treatment of symptomatic vertebrobasilar artery stenosis. Interv Neuroradiol. 2018;24(1):43\u201350.","journal-title":"Interv Neuroradiol"},{"key":"1863_CR9","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1212\/01.wnl.0000256713.23864.be","volume":"68","author":"WJ Jiang","year":"2007","unstructured":"Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, et al. Long-term outcome of elective stenting for symptomatic intracranial vertebrobasilar stenosis. Neurology. 2007;68:856\u20138.","journal-title":"Neurology"},{"key":"1863_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(13)62038-3","volume":"383","author":"CP Derdeyn","year":"2014","unstructured":"Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014;383:333\u201341.","journal-title":"Lancet"},{"key":"1863_CR11","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jama.2015.1693","volume":"313","author":"OO Zaidat","year":"2015","unstructured":"Zaidat OO, Fitzsimmons BF, Woodward BK, et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA. 2015;313:1240\u20138.","journal-title":"JAMA"},{"issue":"11","key":"1863_CR12","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1161\/STROKEAHA.115.009846","volume":"46","author":"HL Lutsep","year":"2015","unstructured":"Lutsep HL, Lynn MJ, Cotsonis GA, et al. Does SAMMPRIS support stenting over medical therapy for subpopulations of patients with intracranial arterial stenosis? Stroke. 2015;46(11):3282\u20134.","journal-title":"Stroke"},{"key":"1863_CR13","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1136\/neurintsurg-2016-012329","volume":"9","author":"B Jia","year":"2017","unstructured":"Jia B, Liebeskind DS, Ma N, et al. Factors associated with perforator stroke after selective basilar artery angioplasty or stenting. J NeuroIntervent Surg. 2017;9:738\u201342.","journal-title":"J NeuroIntervent Surg"},{"issue":"2","key":"1863_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/1591019915581778","volume":"21","author":"P Gao","year":"2015","unstructured":"Gao P, Jiao LQ, Ling F, et al. China angioplasty and stenting for symptomatic intracranial severe stenosis (CASSISS): a new, prospective, multicenter, randomized controlled trial in China. Interv Neuroradiol. 2015;21(2):196\u2013204.","journal-title":"Interv Neuroradiol"},{"issue":"1","key":"1863_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1227\/NEU.0b013e31822dff0f","volume":"70","author":"Z Vajda","year":"2012","unstructured":"Vajda Z, Schmid E, Lindner A, et al. The modified Bose method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the Enterprise stent. Neurosurgery. 2012;70(1):91\u2013101.","journal-title":"Neurosurgery"},{"key":"1863_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12883-015-0443-9","volume":"15","author":"Z Feng","year":"2015","unstructured":"Feng Z, Duan G, Huang H, et al. Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients. BMC Neurol. 2015;15:187.","journal-title":"BMC Neurol"},{"key":"1863_CR17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1161\/STROKEAHA.118.023996","volume":"50","author":"MJ Alexander","year":"2019","unstructured":"Alexander MJ, Chaloupka JC, Zauner A, et al. WEAVE intracra-nial stent trial: final trial results in 150 patients treated on-label. Stroke. 2019;50:889\u201394.","journal-title":"Stroke"},{"key":"1863_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fneur.2018.00533","volume":"9","author":"H Nordmeyer","year":"2018","unstructured":"Nordmeyer H, Chapot R, Aycil A, et al. Angioplasty and stenting of intracranial arterial stenosis in perforator-bearing segments: a comparison between the anterior and the posterior circulation. Front Neurol. 2018;9:533.","journal-title":"Front Neurol"},{"issue":"6","key":"1863_CR19","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1177\/0284185114538793","volume":"56","author":"XQ Chen","year":"2015","unstructured":"Chen XQ, Tian JM, Zuo CJ, et al. Hemodynamic alterations in unilateral chronic middle cerebral artery stenosis patients and the effect of percutaneous transluminal angioplasty and stenting: a perfusion-computed tomography study. Acta Radiol. 2015;56(6):754\u201360.","journal-title":"Acta Radiol"},{"issue":"5","key":"1863_CR20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1177\/1591019919832244","volume":"25","author":"AE Salik","year":"2019","unstructured":"Salik AE, Selcuk HH, Zalov H, et al. Medium-term results of undersized angioplasty and stenting for symptomatic high-grade intracranial atherosclerotic stenosis with Enterprise. Interv Neuroradiol. 2019;25(5):484\u201390.","journal-title":"Interv Neuroradiol"},{"issue":"1","key":"1863_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/1591019917736032","volume":"24","author":"J Wang","year":"2018","unstructured":"Wang J, Zhong CY, Zhang Y, et al. Seven years\u2019 follow-up of comparative study between stenting and medication for treatment of symptomatic vertebrobasilar artery stenosis. Interv Neuroradiol. 2018;24(1):43\u201350.","journal-title":"Interv Neuroradiol"},{"key":"1863_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/neurintsurg-2014-011633","volume":"8","author":"MD Alexander","year":"2016","unstructured":"Alexander MD, Rebhun JM, Hetts SW, et al. Lesion location, stability, and pretreatment management: factors affecting outcomes of endovascular treatment for vertebrobasilar atherosclerosis. J Neurointerv Surg. 2016;8:466\u201370.","journal-title":"J Neurointerv Surg"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01863-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-020-01863-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01863-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T19:36:38Z","timestamp":1627673798000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01863-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1863"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01863-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-24994\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]},"assertion":[{"value":"27 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study is conducted in accordance with the Declaration of Helsinki. Potential participants receive detailed written and oral information on the study procedures and all participants provide written informed consent. Ethics approval of the study was obtained from the Hengyang Central Hospital and Southern Medical University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"289"}}